CPC technology class · C07

C07B - General Methods Of Organic Chemistry

General methods of organic chemistry; apparatus therefor. 8,058 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.

Compiled by PlainPatent · May 15, 2026

8,058
US patents granted: #5/8
in C07: 4.6%
C07 class share: +17%
5-yr velocity

The verdict

According to USPTO PatentsView, General Methods Of Organic Chemistry ranks #191 of 670 CPC technology areas - 8,058 US patents granted since 2015, with recorded grant volume up 17% over five years.

#191
of 670 CPC technology areas: 8,058
US patents granted, 2015–2025: Incyte
leading assignee (89): +17%
grant velocity, last 5 yrs

How C07B's grant cadence moved

Between 2020–2024, C07B recorded 3,673 grants versus 3,129 in 2015–2019 (+17% equal-window velocity). Across complete years, output peaked in 2020 at 823 grants and bottomed in 2015 at 508 (+62% peak-over-trough). Lead assignee Incyte Corporation holds 1.1% of the class ; the top three share 3.0%.

Leaderboard read

C07B concentration, lead at 1.1%

Incyte Corporation leads this historical grant record at 1.1% of C07B - foreign corporation assignees hold 54% of class grants (2,908 of 5,364). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.

Leader's share: 1.1%
Top three share: 3.0%
Lead over #2: 7

Where C07B sits inside C07

Among 8 subclasses in C07 (Organic Chemistry), C07B ranks #5 and holds 4.6% of the parent class's 176,064 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.

C07K 58,046 C07D 54,914 C07C 32,521 C07F 14,249 C07H 6,464 C07J 1,454 C07G 358

Rising assignees active in C07B

Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.

#1 King Faisal University 125x 6 → 747 company-wide · 47 in C07B
#2 SpringWorks Therapeutics, Inc. 27x 1 → 27 company-wide · 8 in C07B
#3 Caamtech, Inc. 18x 1 → 18 company-wide · 15 in C07B
#4 Shaanxi Lighte Optoelectronics Material Co., Ltd. 13x 3 → 39 company-wide · 21 in C07B
#5 Zhangzhou Pien TZE Huang Pharmaceutical Co., Ltd. 13x 1 → 13 company-wide · 6 in C07B

C07B grants by year, peak 2020 (823)

US utility-patent grants per year in C07B, 2015–2025 - recent five years are up 17% versus 2015–2019.

Incyte

89
Novartis

82
Bristol-myers Squibb

67
Abb Vie

64
Pfizer

63
Concert Pharmaceutical…

57
Gilead Sciences

56
Vertex Pharmaceuticals…

55
Merck Sharp & Dohme

54
Janssen Pharmaceutical…

54
Celgene

53
Theravance Biopharma…

51

What this shows Incyte is the most active filer in C07B, holding 89 of the 8,058 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.

View data table

Top patent holders in CPC subclass C07B
Rank	Company	Patents in C07B
#1	Incyte Corporation	89
#2	Novartis AG	82
#3	Bristol-Myers Squibb Company	67
#4	Abb Vie Inc.	64
#5	Pfizer Inc.	63
#6	Concert Pharmaceuticals, Inc.	57
#7	Gilead Sciences, Inc.	56
#8	Vertex Pharmaceuticals Incorporated	55
#9	Merck Sharp & Dohme LLC	54
#10	Janssen Pharmaceuticals, Inc.	54
#11	Celgene Corporation	53
#12	Theravance Biopharma R&D IP, LLC	51
#13	King Faisal University	47
#14	Daiichi Sankyo Company, Limited	47
#15	Mitsubishi Gas Chemical Company, Inc.	42
#16	GE Healthcare Limited	42
#17	Hoffmann-La Roche Inc.	37
#18	Amgen Inc.	34
#19	Council OF Scientific AND Industrial Research	34
#20	Takeda Pharmaceutical Company Limited	34

Footprint here vs. claim strategy

Each dot is a leading C07B assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.

Top 14 C07B assignees by class footprint. Bubble size = patents in C07B. Source: USPTO PatentsView (claim depth is company-wide across all classes).

Classes near C07B's 8,058-grant footprint

Nationwide nearest neighbors for C07B (#191 of 670 by volume ; lead share 1.1%) - not the C07 parent-class siblings above.

Nearest by grant volume

B60H 7,970 C12M 8,154 E04B 7,959 A61C 8,164

Nearest by lead-assignee share

A61P 1.1% Y02A 1.1% F16L 1.1% E02D 1.0%

Questions about C07B

Which company holds the most patents in C07B?

Incyte Corporation leads C07B with 89 patents (1.1% of the subclass). By PatentsView assignee type, foreign corporations account for 54% of class grants.

Which C07B assignees grew fastest recently?

Among assignees with ≥5 grants in C07B, King Faisal University shows the highest company-wide grant multiple (125x: 6 grants in 2019–2021 → 747 in 2022–2024) while holding 47 patents in this subclass. Growth is company-wide, not class-only.

How does C07B compare inside parent class C07?

Inside C07 (Organic Chemistry), C07B ranks #5 of 8 subclasses by grant volume and holds 4.6% of the parent class total. The largest sibling is C07K (58,046 grants).

What to do with this data

C07B in context - here's where to go next.

Incyte Corporation leads C07B with 89 grants in this class. See full portfolio
C07B ranks #191 of 670 by grant volume among all tracked CPC technology areas. See the ranking
Inside parent class C07, the largest sibling subclass is C07K with 58,046 grants. Explore C07K

Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.

Methodology - C07B figures are USPTO PatentsView granted-utility totals for this subclass (8,058 grants in the tracked window).

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.